Synergen, Inc. is a biotechnology company based in Boulder, Colorado, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced technologies to address unmet medical needs, particularly in the fields of regenerative medicine and cellular therapies. With a commitment to scientific excellence, Synergen aims to improve patient outcomes through its cutting-edge research and development efforts, fostering collaboration within the biotech community to drive progress in healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#106 in Boulder, CO

#583 in Colorado

#27,529 in US

#51,801 in the World

Boulder, CO, United States of America

Synergen, Inc.

Forward Citations = 348

24 inventors:

Andreas Sommer (4 out of 4 patents)

Daniel B Rifkin (2 out of 3 patents)

Leu-Fen H Lin (2 out of 14 patents)

4. Franklin D Collins (2 out of 11 patents)

5. Robert C Thompson (2 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synergen, Inc.. Retrieved from https://idiyas.com/company/synergen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]